Canada Foundation for Innovation
OrganisationROR
Awards made
John R. Evans Leaders Fund, A Single-Cell Analysis Lab to investigate the aging mechanisms of oligodendrocyte precursor cells, CFI-2025-223661, 2025, 19 Jun 2025
John R. Evans Leaders Fund, A Single-Cell Analysis Lab to investigate the aging mechanisms of oligodendrocyte precursor cells, CFI-2025-223661, CA$175.5k, 2025, 19 Jun 2025
John R. Evans Leaders Fund, Metabolism and mechanobiology in musculoskeletal aging, injury and disease, CFI-2025-406495, 2025, 19 Jun 2025
John R. Evans Leaders Fund, Metabolism and mechanobiology in musculoskeletal aging, injury and disease, CFI-2025-406495, CA$145.3k, 2025, 19 Jun 2025
John R. Evans Leaders Fund, Biomarkers of Subjective Cognitive Decline (SCD) in Older Adults, CFI-2025-489685, 2025, 19 Jun 2025
John R. Evans Leaders Fund, Biomarkers of Subjective Cognitive Decline (SCD) in Older Adults, CFI-2025-489685, CA$165k, 2025, 19 Jun 2025
John R. Evans Leaders Fund, Advanced imaging for skeletal health across the lifespan, CFI-2025-966855, 2025, 18 Mar 2025
John R. Evans Leaders Fund, Advanced imaging for skeletal health across the lifespan, CFI-2025-966855, CA$116.3k, 2025, 18 Mar 2025
John R. Evans Leaders Fund, A novel laboratory to study sarcopenia and the neuromuscular control of movement across the ageing spectrum, CFI-2025-634169, 2025, 18 Mar 2025
John R. Evans Leaders Fund, A novel laboratory to study sarcopenia and the neuromuscular control of movement across the ageing spectrum, CFI-2025-634169, CA$80k, 2025, 18 Mar 2025
Sources: openalex.org
Funded papers
Declining ribosome function limits oocyte longevity
30 Sept 2026
15 Sept 2026
14 Sept 2026
11 Sept 2026
10 Sept 2026
CFI MSIF 42495, 2 Sept 2026
Sources: api.crossref.org
Papers
Lancet regional health. Americas, 24 Sept 2026